A rising star in nanotechnology, Dmitri Lapotko, has received his second retraction within a month over “a finding of research misconduct” that the university will apparently only disclose on a need-to-know basis.
According to the notice, the journal’s editor and publisher issued the retraction after Lapotko’s former institution—Rice University in Houston—notified them of research misconduct and cited figure duplication issues, which meant the results “should not be relied upon and may be scientifically unsound.”
We recently covered the Belarusian physicist’s first retraction in the journal Theranostics, in which an official at Rice would not confirm a misconduct inquiry, telling us that, “Rice University’s investigations of research misconduct are confidential.”
This time, however, the retraction notice explicitly states that a Rice University research integrity officer reported research misconduct to the journal Applied Physics Letters (APL). We contacted the official, B.J. Almond, who still stuck to the original script: Continue reading Research misconduct finding — which university won’t discuss — leads to second retraction for prominent physicist
In an unusual turn of events, a nutrition paper has come back to life a year after being pulled from its original publication.
Researchers in China have retracted a paper and corrected three others in a plant journal, citing problems with multiple figures.
When two surgeons in Greece learned that a patient had developed a rare side effect following weight loss surgery, they were eager to publish the case.
A food science journal has retracted a paper over “a breach of reviewer confidentiality,” after editors learned it contained text from an unpublished manuscript — which one of the authors appears to have reviewed for another journal.
Ask and ye shall receive: A journal has retracted a 2014 paper by Paolo Macchiarini,
Despite taking some serious hits, a 2006 letter in
By now, most of our readers are aware that some fields of science have a reproducibility problem. Part of the problem, some argue, is the publishing community’s bias toward dramatic findings — namely, studies that show something has an effect on something else are more likely to be published than studies that don’t.
A scientist who sued his employer for millions of dollars has earned two more retractions, for papers that had already been flagged by the journal.